Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
Clinical trial NCT05843643 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05843643
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-25
- Primary completion
- 2027-03-01
- Enrollment
- 1014
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.